Detalhe da pesquisa
1.
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto.
Ann Oncol
; 29(12): 2341-2347, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30335131
2.
[Retrieval of a migrated plastic stent in a 51-year-old man]. / Bergung eines migrierten Doppel-Pigtail-Stents bei einem 51-jährigen Patienten.
Internist (Berl)
; 59(10): 1100-1105, 2018 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-29663019
3.
Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).
Ann Oncol
; 27(12): 2236-2241, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789470
4.
Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial.
Cancer Chemother Pharmacol
; 64(2): 401-6, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19104816
5.
Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial.
Ann Oncol
; 17(6): 957-61, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16600975